(Q37993138)

26 August 2017

0 references

Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis (English)

1 reference

26 August 2017

0 references

0 references

cardiovascular disease

1 reference

1 reference

F M Islam

1

1 reference

26 August 2017

J Wu

series ordinal

2

1 reference

26 August 2017

J Jansson

series ordinal

3

1 reference

26 August 2017

D P Wilson

series ordinal

4

1 reference

26 August 2017

publication date

14 March 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

13

1 reference

26 August 2017

issue

8

1 reference

26 August 2017

page(s)

453-468

1 reference

Projections of global mortality and burden of disease from 2002 to 2030

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Risk factors for myocardial infarction in HIV-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

An open-label, prospective, observational study of the incidence of coronary artery disease in patients with hiv infection receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Efficacy of contact lens systems against recent clinical and tap water Acanthamoeba isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Dyslipidemia and cardiovascular disease risk factor management in HIV-1-infected subjects treated with HAART in the Spanish VACH cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Protease inhibitors and cardiovascular disease: analysis of the Los Angeles County adult spectrum of disease cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Some general points in estimating heterogeneity variance with the DerSimonian-Laird estimator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Systematic reviews: synthesis of best evidence for clinical decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Ischemic Heart Disease in HIV-Infected and HIV-Uninfected Individuals: A Population-Based Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.00996.X

10.1111/J.1468-1293.2012.00996.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference